These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 34879114)

  • 1. Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signaling pathway.
    Lee SW; Kim SM; Hur W; Kang BY; Lee HL; Nam H; Yoo SH; Sung PS; Kwon JH; Jang JW; Kim SJ; Yoon SK
    PLoS One; 2021; 16(12):e0261067. PubMed ID: 34879114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway.
    Xiu AY; Ding Q; Li Z; Zhang CQ
    Drug Des Devel Ther; 2021; 15():3643-3659. PubMed ID: 34456560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tormentic acid inhibits hepatic stellate cells activation via blocking PI3K/Akt/mTOR and NF-κB signalling pathways.
    Lin X; Li Y; Zhang X; Wei Y; Wen S; Lu Z; Huang Q; Wei J
    Cell Biochem Funct; 2021 Jan; 39(1):77-87. PubMed ID: 32564421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGFBPrP1 accelerates autophagy and activation of hepatic stellate cells via mutual regulation between H19 and PI3K/AKT/mTOR pathway.
    Huang TJ; Ren JJ; Zhang QQ; Kong YY; Zhang HY; Guo XH; Fan HQ; Liu LX
    Biomed Pharmacother; 2019 Aug; 116():109034. PubMed ID: 31152924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of EPCAM suppresses hepatic fibrosis and hepatic stellate cell proliferation in mice with alcoholic hepatitis via the PI3K/Akt/mTOR signaling pathway.
    Zhang Z; Wen H; Weng J; Feng L; Liu H; Hu X; Zeng F
    Cell Cycle; 2019 Sep; 18(18):2239-2254. PubMed ID: 31378124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways.
    Fang B; Wen S; Li Y; Bai F; Wei Y; Xiong Y; Huang Q; Lin X
    Int Immunopharmacol; 2021 Mar; 92():107208. PubMed ID: 33444919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ROS-dependent inhibition of the PI3K/Akt/mTOR signaling is required for Oroxylin A to exert anti-inflammatory activity in liver fibrosis.
    Shen M; Guo M; Wang Z; Li Y; Kong D; Shao J; Tan S; Chen A; Zhang F; Zhang Z; Zheng S
    Int Immunopharmacol; 2020 Aug; 85():106637. PubMed ID: 32512269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guizhi Fuling Wan attenuates tetrachloromethane-induced hepatic fibrosis in rats via PTEN/AKT/mTOR signaling pathway.
    Yao H; He Q; Xiang L; Liu S; Yang Z; Li X; Liu W; Huang C; Wang B; Xie Q; Gao Y; Zheng C; Li X
    J Ethnopharmacol; 2024 Nov; 334():118593. PubMed ID: 39032663
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Dong Z; Guan H; Wang L; Liang L; Zang Y; Wu L; Bao L
    Mol Med Rep; 2024 Nov; 30(5):. PubMed ID: 39219289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethyl Acetate Fraction of Dicliptera chinensis (L.) Juss. Ameliorates Liver Fibrosis by Inducing Autophagy via PI3K/AKT/mTOR/p70S6K Signaling Pathway.
    Liu Y; Bi YM; Pan T; Zeng T; Mo C; Sun B; Gao L; Lyu ZP
    Chin J Integr Med; 2022 Jan; 28(1):60-68. PubMed ID: 34105096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.
    Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C
    Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maltol Mitigates Thioacetamide-induced Liver Fibrosis through TGF-β1-mediated Activation of PI3K/Akt Signaling Pathway.
    Mi XJ; Hou JG; Jiang S; Liu Z; Tang S; Liu XX; Wang YP; Chen C; Wang Z; Li W
    J Agric Food Chem; 2019 Feb; 67(5):1392-1401. PubMed ID: 30644744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-195-3p promotes hepatic stellate cell activation and liver fibrosis by suppressing PTEN expression.
    Wang A; Bu FT; Li JJ; Zhang YF; Jia PC; You HM; Wu S; Wu YY; Zhu S; Huang C; Li J
    Toxicol Lett; 2022 Feb; 355():88-99. PubMed ID: 34838997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K/AKT/mTOR/p70S6K1 signaling pathways.
    Peng R; Wang S; Wang R; Wang Y; Wu Y; Yuan Y
    Discov Med; 2017 Feb; 23(125):81-94. PubMed ID: 28371611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
    Wu SM; Li TH; Yun H; Ai HW; Zhang KH
    Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loureirin B ameliorates cholestatic liver fibrosis via AKT/mTOR/ATG7-mediated autophagy of hepatic stellate cells.
    Cheng WY; Zeng XX; Cheng P; Zhang JX
    Eur J Pharmacol; 2024 May; 971():176552. PubMed ID: 38580181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of Idelalisib on carbon tetrachloride-induced liver fibrosis via microRNA-124-3P/phosphatidylinositol-3-hydroxykinase signalling pathway.
    Li X; Li H; Zhang S; Zhang R; Li J; Wei Y; Yang C; Zhang F; Zhou H
    J Cell Mol Med; 2021 Dec; 25(24):11185-11197. PubMed ID: 34747105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.
    Riaz F; Chen Q; Lu K; Osoro EK; Wu L; Feng L; Zhao R; Yang L; Zhou Y; He Y; Zhu L; Du X; Sadiq M; Yang X; Li D
    J Cell Mol Med; 2021 Apr; 25(8):4073-4087. PubMed ID: 33689215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cucurbitacin E ameliorates hepatic fibrosis in vivo and in vitro through activation of AMPK and blocking mTOR-dependent signaling pathway.
    Wu YL; Zhang YJ; Yao YL; Li ZM; Han X; Lian LH; Zhao YQ; Nan JX
    Toxicol Lett; 2016 Sep; 258():147-158. PubMed ID: 27363783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking P2X4 purinergic receptor attenuates alcohol-related liver fibrosis by inhibiting hepatic stellate cell activation through PI3K/AKT signaling pathway.
    Li ZX; Sheng XD; Wang YL; Wen Lv X
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109326. PubMed ID: 36252487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.